Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Will US Daily Covid-19 Cases Pass 100,000?

Published 03/07/2020, 12:38
Updated 21/10/2020, 09:15

The US is seeing record numbers of new covid-19 cases on a daily basis – will it continue to accelerate this week?

US
In a week exceedingly light on top tier data, investors may be forced to pay more attention to the coronavirus headlines they have been so desperate to ignore.

Over the last couple of weeks, America’s number of new daily covid-19 cases has grown from the 30,000s to the 40,000s to 50,000s. Yet repeatedly the markets have put their fingers in their ears, instead focusing on things like the strength of June’s nonfarm jobs report or the (early days) positive vaccine news from Pfizer (NYSE:PFE) and BioNTech.

Dr Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases and maybe the most prominent member of the White House Coronavirus Task Force, has spoken of what is ‘going to be a very disturbing’ US death toll – which is currently around 130,000 – while warning that daily cases could soon hit a staggering 100,000. And this is more than 3 months into a pandemic.

Florida is almost a microcosm for the US as a whole, the state regularly accounting for a fifth of the overall daily total of new cases, following a lockdown that was a lockdown in name alone.

As mentioned, without anything like a nonfarm jobs report to pull focus – there’s the latest services PMIs on Monday, unemployment claims on Thursday, PPI on Friday, and not much else – investors may have little option but to stare those grim coronavirus figures in the face.

There are, of course, a couple of factors that could ride in white knight-style. Any more upbeat vaccine news from the various labs working on one has shown time and again to be a market-lifter. And there have also been reports Congress is considering a new fiscal spending bill – potentially including stimulus checks and back-to-work bonuses – an update on which could be handy.

UK
Just like in the US, there’s not a whole lot of data on offer in the UK this week, leaving the FTSE at the mercy of macro-winds.

The latest construction PMI arrives on Monday, with the Halifax HPI on Tuesday, and the CB leading index on Friday.

The pound will also be keeping an eye on the Brexit situation, after the most recent round of talks ended in a harmful stalemate.

In terms of the corporate calendar, the highlights are Halfords, JD Sports, Electrocomponents (LON:ECM) and Reach on Tuesday, and Persimmon (LON:PSN), PageGroup (LON:PAGE) and Superdry (LON:SDRY) on Thursday.

Eurozone
Over in the Eurozone, there are the region-wide retail sales reading on Monday, the French trade balance number on Tuesday, the latest EU economic forecasts on Wednesday, and the French and Italian industrial production figures on Friday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Disclaimer: Spreadex provides an execution only service and the comments above do not constitute (or should not be construed as constituting) investment advice or recommendations, or a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any person placing trades based on their interpretations of the above comments does so entirely at their own risk. Spreadex Ltd is a financial and sports spread betting and sports fixed odds betting firm, which specialises in the personal service and credit area. Founded in 1999, Spreadex is recognised as one of the longest established spread betting firms in the industry with a strong reputation for its high level of customer service and account management.

In relation to spread betting, Spreadex Ltd is authorised and regulated by the Financial Conduct Authority. Spread betting carries a high level of risk to your capital and can result in losses larger than your initial stake/deposit. It may not be suitable for everyone, so please ensure you fully understand the risks involved."

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.